Tempest Therapeutics Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2021
August 12, 2021 at 04:01 pm EDT
Tempest Therapeutics Inc. reported financial results for the second quarter and Six months ended June 30, 2021. For the quarter, the company's Operating loss was USD 6,785,000 against USD 5,238,000 a year ago. Net loss was USD 7,058,000 against USD 5,229,000 a year ago. Net loss per share was USD 7.63 against USD 11.42 a year ago.
For the Six months, the company's Operating loss was USD 11,912,000 against USD 9,541,000 a year ago. Net loss was USD 12,413,000 against USD 9,457,000 a year ago. Net loss per share was USD 17.30 against USD 21.28 a year ago.